Wacker Chemie AG finished Q3 2022 with significant sales growth. From July through September, the Munich-based chemical company generated sales of €2,132.2 million.
Wacker Chemie AG continued on its growth trajectory in Q2 2022.
mk2 Biotechnologies, WACKER and the Technical University of Munich (TUM) today announced their joint project targeting the development, large-scale production and purification of antimicrobial peptides (AMPs) for diverse applications.
Today, the Annual Shareholders’ Meeting approved the highest dividend in the company’s history.
Wacker Chemie AG finished Q1 2022 with new highs in sales and earnings.